Ej. Blom et al., Transforming growth factor-beta 1 incorporation in a calcium phosphate bone cement: Material properties and release characteristics, J BIOMED MR, 59(2), 2002, pp. 265-272
The bone regenerative properties of calcium phosphate cements (CPCs) may be
improved by the addition of growth factors, such as recombinant human tran
sforming growth factor-beta1 (rhTGF-beta1). Previously, we showed that rhTG
F-beta1 in CPC stimulated the differentiation of preosteoblastic cells from
adult rat long bones. The intermixing of rhTGF-beta1 in CPC, which was sub
sequently applied to rat calvarial defects, enhanced bone growth around the
cement and increased the degradation of the cement. However, it is unknown
whether the addition of rhTGF-beta1 changes the material properties of CPC
and what the characteristics of the release of rhTGF-beta1 from CPC are. T
herefore, we determined in this study the release of rhTGF-beta1, in vitro,
from the cement pellets as implanted in the rat calvariae, The possible in
tervening effects of rhTGF-beta1 intermixing on the clinical compliance of
CPC were studied through an assessment of its compressive strength and sett
ing time, as well as its crystallinity, calcium-to-phosphorus ratio, porosi
ty, and microscopic structure. We prepared CPC by mixing calcium phosphate
powder (58% alpha -tricalcium phosphate, 25% anhydrous dicalcium phosphate,
8.5% calcium carbonate, and 8.5% hydroxyapatite) with a liquid (3 g/mL). T
he liquid for standard CPC consisted of water with 4% disodium hydrogen pho
sphate, whereas the liquid for modified CPC was mixed with an equal amount
of 4 mM hydrochloride with 0.2% bovine serum albumin. The hydrochloride liq
uid contained rhTGF-beta1 in different concentrations for the release exper
iments. Most of the rhTGF-beta1 incorporated in the cement pellets was rele
ased within the first 48 h. For all concentrations of intermixed rhTGF-beta
1 (100 ng to 2.5 mg/g of CPC, approximately 0.5% was released in the first
4 h, increasing to 1.0% after 48 h. Further release was only about 0.1% fro
m 2 days to 8 weeks. CPC modification slightly increased the initial settin
g time at 20 degreesC from 2.6 to 5 min but had no effect on the final sett
ing time of CPC at 20 degreesC or the initial and final setting times at 37
degreesC. The compressive strength was increased from 18 MPa in the standa
rd CPC to 28 MPa in the modified CPC only 4 h after mixing. The compressive
strength diminished in the modified CPC between 24 h and 8 weeks from 55 t
o 25 MPa. No other significant change was found with the CPC modification f
or rhTGF-beta1. X-ray diffraction revealed that standard and modified CPCs
changed similarly from the original components, alpha -tricalcium phosphate
and anhydrous, dicalcium phosphate, into an apatite cement. The calcium-to
-phosphorus ratio, as determined with an electron-microprobe, did not diffe
r for standard CPC and modified CPC. Standard and modified CPCs became dens
e and homogeneous structures after 24 h, but the modified CPC contained mor
e crystal plaques than the standard CPC, as observed with scanning electron
microscopy (SEM). SEM and backscattered electron images revealed that afte
r 8 weeks the cements showed equally and uniformly dense structures with mi
croscopic pores (<1 mum). Both CPCs showed fewer crystal plaques at 8 weeks
than at 24 h. This study shows that CPC is not severely changed by its mod
ification for rhTGF-beta1. The prolonged setting time of modified cement ma
y affect the clinical handling but is still within acceptable limits. The c
ompressive strength for both standard and modified cements was within the r
ange of thin trabecular bone; therefore, both CPCs can withstand equal mech
anical loading. The faster diminishing compressive strength of modified cem
ent from 24 h to 8 weeks likely results in early breakdown and so might be
favorable for bone regeneration.
Together with the beneficial effects on bone regeneration from the addition
of rhTGF-beta1 to CPC, as shown in our previous studies, we conclude that
the envisaged applications for CPC in bone defects are upgraded by the inte
rmixing of rhTGF-beta1. Therefore, the combination of CPC and rhTGF-beta1 f
orms a promising synthetic bone graft. (C) 2001 John Wiley & Sons, Inc.